Dimitri Skvortsov

Title: Innovations of Dimitri Skvortsov

Introduction

Dimitri Skvortsov is an accomplished inventor based in Orinda, California. He has made significant contributions to the field of medical diagnostics, particularly in the detection of copy number variations (CNVs) associated with various medical conditions. With a total of 3 patents to his name, Skvortsov's work has the potential to impact prenatal testing and genetic analysis.

Latest Patents

One of Skvortsov's latest patents is titled "Limit of detection based quality control metric." This patent provides methods and systems for sample quality control in CNV detection using test samples that comprise cell-free nucleic acid fragments originating from both a mother and a fetus. The method involves determining an exclusion region defined by a fetal fraction limit of detection (LOD) curve, which varies with coverage values and indicates the minimum values of fetal fractions needed to achieve a detection criterion given different coverages.

Another notable patent is "Using cell-free DNA fragment size to determine copy number variations." This patent discloses methods for determining CNVs known or suspected to be associated with a variety of medical conditions. The methods include determining CNVs of fetuses using maternal samples that comprise both maternal and fetal cell-free DNA. The patent also provides methods to improve the sensitivity and specificity of sequence data analysis by deriving a fragment size parameter.

Career Highlights

Dimitri Skvortsov has worked with prominent companies in the biotechnology sector, including Verinata Health, Inc. and Illumina Corporation. His experience in these organizations has allowed him to develop innovative solutions that enhance the accuracy of genetic testing.

Collaborations

Throughout his career, Skvortsov has collaborated with notable professionals in the field, including Sven Duenwald and David A Comstock. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Dimitri Skvortsov's innovative work in the field of medical diagnostics showcases his expertise and commitment to improving prenatal testing methods. His patents reflect a deep understanding of genetic analysis and its implications for healthcare.